Preview Mode Links will not work in preview mode

Sep 20, 2021

Featuring perspectives from Dr Kathy D Miller and Ms Kelly Leonard, including the following topics:

  • Introduction: The Practice-Changing Summer of 2021 (0:00)
  • Case 1: A woman in her early 60s with ER-positive, HER2-negative localized breast cancer (13:06)
  • Case 2: A woman in her early 50s with ER-positive, HER2-negative...


Sep 14, 2021

Featuring perspectives from Dr Karen A Gelmon, including the following topics:

  • Management of Metastatic HER2-Positive Breast Cancer
    • Introduction (0:00)
    • Case: A woman in her late 60s with HER2-positive breast cancer with symptomatic brain metastases — Sulfi Ibrahim, MD (5:26)
    • Case: A woman in her late 30s with de...


Jul 23, 2021

Featuring an interview with Dr Sara M Tolaney, including the following topics:

  • Role of the Breast Cancer Index® in predicting benefit from extended aromatase inhibitor therapy for hormone receptor (HR)-positive breast cancer  (0:00)
  • ADAPT HR-positive/HER2-negative trial: Prognostic utility of genomic assays, clinical...


Jul 20, 2021

Proceedings from a daylong multitumor educational webinar in partnership with the Texas Society of Clinical Oncology, featuring key clinical presentations and papers in breast cancer. Featuring perspectives from Drs Virginia F Borges and Harold J Burstein, including the following topics:

  • Introduction 
  • Cases from the...


Jul 17, 2021

Featuring slide presentations and related discussion from Drs Matthew P Goetz, Hope S Rugo and Melinda Telli, including the following topics:

  • Evolving Clinical Decision-Making for Patients with ER-Positive Localized Breast Cancer — Matthew P Goetz, MD (0:00)
  • Selection and Sequence of Therapy for...